For years, Kasia Lipska, MD, MHS, associate professor of medicine (endocrinology) at Yale School of Medicine (YSM), has been ...
Large and small drugmakers are vying for a piece of what analysts view as one of the biggest market opportunities in the pharma industry's history. Here’s what’s coming next.
Explore the latest in obesity treatment options, including bariatric surgery and GLP-1 medications. Learn how to choose the ...
The North Carolina state treasurer is taking on drugmakers Novo Nordisk and Eli Lilly in an attempt to lower drug costs for ...
GLP-1 drugs like Ozempic and Wegovy can help most people lose weight, but they don’t work for everyone. Here are 5 common ...
which does not cover anti-obesity medications for weight-loss management. In the United States, Wegovy’s list price is US$1,350 for one month’s supply. And in the United Kingdom, where Wegovy ...
Congressional leaders and the administration must work together to expand access to anti-obesity medications through Medicare ...
Less than half of large employers currently cover the new generation of obesity drugs, but an additional 18% say they’re considering adding them amid surging interest. Nov. 11, 2023 In some ...
LONDON — Following a nine-month investigation, European regulators said Friday they have found no evidence that GLP-1 drugs like Ozempic and Wegovy cause suicidal thoughts or actions. The ...
Medscape Medical News, April 17, 2024 Amino Acid Supplement Cuts Liver Risks in PCOS and Obesity A proprietary essential amino ... Week in Cardiology Obesity drugs as ASCVD-modifiers, HR monitors ...
Ozempic and weight-loss drugs raise hopes for obesity, but complexities exist. The Ozempic buzz plays into ideas of fat stigma and fatphobia. The Ozempic doesn't work same for everyone.
“It’s not all about weight loss,” he said, adding that semaglutide ... and often linked with obesity. The growing list of potential uses for obesity drugs has been driving up expectations ...